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G R A P H I C A L A B S T R A C TA B S T R A C T
While a number of post-translational modiﬁcations (PTM), such as phosphorylation and ubiquitination, have
been extensively studied, lysine methylation is emerging as an important PTM with implications in a growing
number of diverse cellular processes. To date, there are approximately 5000 identiﬁed methylation sites on non-
histone proteins, and as the methyllysine proteome expands it becomes important to identify the lysine
methyltransferase enzymes responsible for each methylation event. The use of peptide SPOT methylation assay
has proven to be a useful in the identiﬁcation and validation of novel substrates for lysine methyltransferase
enzymes as it uses a weak beta emitter coupled with ﬂuorography to detect methylation events. The method
described in this paper provides improvements to the typical protocol for this assay, as a highly sensitive tritium
assay can be developed with less radioactivity than previously described. This protocol provides an inexpensive
alternative toweak beta signal enhancer sprays andwashes for use in lysinemethylationpeptide SPOTarrays, and
a simple open-source method for array quantiﬁcation.
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Protocol name Highly sensitive in vitro SPOT methylation assay
Name and reference of
original methodAdapted from: S. Kudithipudi, D. Kusevic, S. Weirich, A. Jeltsch. Speciﬁcity analysis of protein
lysine methyltransferases using SPOT peptide arrays. J Vis Exp., 93 (2014)Resource availability  Adenosyl-L-methionine, S-[methyl-3H] (Perkin Elmer, Cat# NET155V250UC)
 2,5-Diphenyloxazole (DPO) (Sigma-Aldrich, Cat# D210404)
 Amersham Hyperﬁlm MP (GE Healthcare Life Sciences, Cat# 28906842)
 ImageJ software (available at http://imagej.nih.gov/ij/)Value of the Protocol
 Simple method to identify in vitro peptide substrates and determine substrate speciﬁcity of lysine methyltransferase
(KMT) enzymes Optimized concentration of radioactivity for a safer and more cost-efﬁcient method Effective enhancer alternative described for expensive tritium enhancer sprays for array-based ﬂuorometry assays Open-source array quantiﬁcation for experimental analysisProtocol background
It is well-established that lysinemethyltransferase (KMT) enzymes play a role in themethylation of
histones and in effect, the regulation of gene expression in the nucleus. In recent years, however, it has
become evident that these enzymes play a more complex role in the cell, as approximately
5000 methylation sites on non-histone proteins have been identiﬁed. Since only approximately
50 KMTs have been identiﬁed, it would appear that each one is capable of methylating a fairly large
subset of the outlined methyllysine proteome – the question lies in which enzymes are methylating
which substrates. Furthermore, it has been demonstrated that some KMTs (e.g. SMYD3, EZH2, G9a,
etc.) are over-expressed or dysregulated in many different types of cancer [1]. While their roles in
terms of histone lysine methylation have been elucidated [2] recent research has focused on
identifying novel cytoplasmic substrates and investigating possible non-histone mechanisms of
action that propagate the diseases. The SPOT methylation array using adenosyl-L-methionine, S-
[methyl-3H], ﬁrst used in 2008 by Rathert et al. [3], has proven to be an effective method for
identifying new substrates of KMTs and is now widely used. While effective weak beta emitter
enhancer sprays and washes are commercially available, the method described below provides an
inexpensive alternative for producing clear images of radioactively labelled peptide arrays using 2,5-
diphenyloxazole (DPO). This method also provides the optimized amounts of radioactivity needed to
reduce the potentially high costs of in vitro methylation assays, and is able to use a lower
concentration of radioactivity than previously reported [4].
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Step 1: preparation of peptide SPOT arrays
Custom peptide arrays can be synthesized using Fmoc chemistry with specialized equipment (e.g.,
Intavis ResPep SL) directly to aminated cellulose membranes [5]. As a low cost alternative to
purchasing commercially available membranes, the aminated cellulose membrane can also be
prepared in lab prior to peptide synthesis [19_TD$DIFF] 6]. Following synthesis and deprotection of peptides, the
arrays can be washed 6 with dichloromethane (DCM), followed by two washes with anhydrous
ethanol. Membranes are then dried overnight in a desiccator and can then be used for
methyltransferase assays.
Alternative step 1: preparation of peptide dot blots
Materials
 Blocking buffer (50mM Tris [pH 7.4],150mM NaCl, 0.05% tween 20, 5% nonfat skim milk)
 TBS-T buffer (50mM Tris [pH 7.4], 150mM NaCl, 0.05% tween 20)
 Nitrocellulose membrane (Sigma Aldrich, Cat# N8520)
 5mM Peptide
Procedure
1. Spot 1mL of substrate peptide onto a nitrocellulose membrane for a total of 5 nmol of peptide per
spot.
2. Allow peptides to air dry on the nitrocellulose membrane.
3. Block array for 1 h with blocking buffer on a rocking platform at RT.
4. Wash array once with TBS-T buffer for 5min on a rocking platform.
5. Array can be stored (or frozen at 20C) in TBS-T for future use.
Step 2: in vitro methylation
Materials
 Methylation buffer (50mM Tris [pH 8.5], 2mM MgCl2, 1mM dithiothreitol (DTT))
Note: DTT should be added immediately before use as it oxidizes in solution Adenosyl-L-methionine, S-[methyl-3H] (i.e., [3H]SAM) (Perkin Elmer, Cat# NET155V250UC)
 Active KMT enzyme
 Plastic container with lid
Procedure
(1) Peptide array is initially incubated in 6mL of methylation buffer, without added [3H]SAM or KMT
enzyme, for 10min
(2) Remove the 6mL of methylation buffer from the array and add 6mL of fresh methylation buffer
with 0.466mM[3H]SAM (speciﬁc activity: 80Ci/mmol) and 0.1mM–1mMof active KMTenzyme to
the array. The amount of active KMT added will depend on the activity of the KMT. Typically,
0.5mM is a good place to begin assays with.Note: The outlined procedure uses volumes and equipment appropriate for an 8.5 cm 6 cm peptide
array. Volumes and incubation box should be adjusted based on array size, such that the array is fully
submerged in liquid during incubation.
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(4) Leave the array to incubate overnight on a rocking platform at room temperature.Step 3: detection and development
While there are commercially available means of enhancing and detecting the weak radioactivity
emitted by tritium such as enhancing sprays and phosphor screens, they are rather pricey. In the place
of these products, a solution of 7% 2,5-Diphenyloxazole (DPO) in ethanol, in combination with
intensifying screens, can be used and have been shown to effectively enhance the radioactive signal
and produce clear ﬁlm images of peptide arrays. If available, phosphor screens and a phosphoimager
can be used in the place of the ﬁlm described, as sensitivity can be higher and the exposure time can
potentially be reduced.
Materials
 Wash Buffer (100mM NH4HCO3, 1% sodium dodecyl sulfate (SDS))
 2,5-Diphenyloxazole (DPO) (Sigma-Aldrich, Cat# D210404)
 Ethanol, anhydrous
 Forceps
 Plastic food wrap
 Film developer solution (e.g., Ilford ilfosol 3, Cat# 1131778)
 Film ﬁx solution (e.g., Ilford rapid ﬁxer, Cat# 1984253)
 Amersham Hyperﬁlm MP (GE Healthcare Life Sciences, Cat# 28906842)
 Radiographic ﬁlm cassette
 Carestream BioMax TransScreen LE Intensifying screens (Fisher Scientiﬁc, Cat# 05-728-67)
Procedure
1. Prepare a 7%DPO solution by dissolving 7 g of DPO in 100mL ethanol (thismixture can be stored at
room temperature for later use). This will solution will be used later in the procedure to enhance
the 3H signal from the array.2. Next, remove themethylation buffer from array into a labeled radioactive waste storage container
for later disposal.3. Add 10mL of wash buffer to the array and incubate the array on a rocker for 3min at RT.
4. Repeat wash step with fresh wash buffer 5 for 3min
5. Following washing of the array, using forceps transfer the array to a new containing enough
anhydrous ethanol to completely submerge the array. Incubated in ethanol on a rocking platform
for 2min.6. Following incubation of the array in ethanol, remove the ethanol and enough of the 7% DPO
solution to complete submerge the array. Gently agitate for 2min to ensure uniformdistribution of
the DPO solution.7. Remove the array from the DPO solution and allowed to dry completely on ﬁlter paper
(approximately 3 h or overnight) prior to array ﬂuorography.8. Prepare the radiographic ﬁlm cassette by attaching intensifying screens (Carestream BioMax
TransScreen LE) to both the inner bottom and inner cover of the cassette. This will help to enhance
the 3H signal from the array.9. Carefully wrap the dry array with a single layer of plastic wrap. Place the array into the cassette.
10. In complete darkness, remove a sheet of detection ﬁlm (Amersham Hyperﬁlm MP) and cut one
corner tomaintain proper orientation in future analysis. Add theﬁlm to the cassette alongwith the
prepared array.11. Close the cassette and expose the ﬁlm to array ﬂuorography at 80 C. Exposure time will be
dependant on the activity of the KMT enzyme and substrate concentration. Most array exposures
will be in the range of hours to days at 80 C. It is recommended to carry out an initial 24 h
exposure and adjust exposure time from the obtained results.
[(Fig._1)TD$FIG]
Fig. 1. SMYD3 methylation determined by in vitro substrate arrays. A) The amino acid sequences of two validated
SMYD3 substrates. The lysine-speciﬁcmethylation site is underlined and central to the substrate peptides. B) Methylation array
exposure times on for both the MAP3K2 and VEGFR1 validated SYMD3 substrate peptides. C) Visual representation image of
digitized SPOT array used for quantiﬁcation of SPOT intensity. Analysis of SPOT intensity, and SMYD3 substrate activity, was
determined by densitometry of the 3H signal. D) Histograms show relative quantiﬁcation of 3H signal as detected from the SPOT
arrays at different exposure times.
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under a safe light (Fig. 1b).Step 4: quantiﬁcation
In most cases, specialized software is required for the detection and quantiﬁcation of array-
formatted images. To observe and quantify the peptide array, a free open-source program can be used
for efﬁcient and reliable spot quantiﬁcation to compare intensity values.
Materials
 Film imager (e.g., Bio-Rad GS-800 calibrated densitometer)
 Computer with the ImageJ program installed (http://imagej.nih.gov/ij/)
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1. Open the ImageJ program and install the ‘Protein Array Analyzer’macro by clicking on the “toolsets”
menu icon of the ImageJ tool bar. If this is not available, download the macro directly (https://
imagej.nih.gov/ij/macros/toolsets/) and following instructions to install.2. Open the array imagewithin the ImageJ program. Click the “Array Analysis Menu” and select “Array
Analysis” menu to display the graphical interface required to analyze the opened array image. This
action also proposes a method of background correction (none, liner, or paraboloid). It is suggested
to use default settings for background subtraction.3. Within the interface, optimize the visualization by activating some options available such as setting
the diameter of the array spots for analysis. The spot diameter must be properly set, such that the
automatically positioned spots of the array do not overlap. Click anywhere within the array and
adjust the ‘+’ and ‘’ buttons in the left-most icon to change the spot size. The circle radius deﬁnes
the quantiﬁcation area.4. Set the number of columns (nCol.) and rows (nLin.) you wish to analyze in the array image.
5. Located to the right of the nLin icon, set the three required locations (top-left, top-right, and bottom
left) using the respective icons. To set a mark, ﬁrst click on one of the (ﬁrst) top-left, (second) top-
right, or (third) bottom-left icons, thenposition on a cross hair icon initially located in the top-left of
the screen and drag the cursor to the correct location corresponding to your selection (i.e., top-left,
top-right, or bottom left). Complete this for all three positions individually to coordinate the three
corners of the array. Icons will turn from ‘red’ to ‘green’ once set.6. The interface will then automatically place outlines around your spots to be analyzed. If
adjustments are required, simply readjust the marker positions.7. Once all spots are appropriately positioned, click the “Model” button to obtain the array
quantiﬁcation to be used for analysis and a modeled image of the array (Fig. 1C).
Method validation
The described method was used to effectively two known and well-studied non-histone
substrates of SMYD3; a KMT that has been found to be over-expressed in many types of cancer [7].
While some of this KMT’s action in the propagation of cancer has been elucidated, including its
methylation of MAP3K2 contributing to Ras-driven cancer [8], much remains unknown about its
action in the cell. Fig. 1 displays the data obtained from this method for the two previously identiﬁed
non-histone substrates –MAP3K2 and VEGFR1. Since both of the substrate peptides containmultiple
lysine residues that may also be subject to SMYD3-induced methylation in vitro (i.e., passenger
lysine) (Fig. 1A), four variations of the peptides were synthesized on each array to act as methyl-site
speciﬁc controls – with both lysine residues present, with either the passenger lysine or central
lysine mutated to an alanine residue, and with both lysine residues mutated to alanine (Fig. 1B). As
shown in Fig. 1D, an exposure time of 3–5 days resulted in a weak signal from the passenger lysine,
demonstrating the importance of proper optimization of array exposure. An exposure time of 24 h
was found to be optimal for this particular array. It should be noted that this method can be adapted
for a wide variety of methyltransferase enzymes, and other arrays utilizing tritium detection
methods.
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